Veopoz Side Effects
Generic name: pozelimab
Medically reviewed by Drugs.com. Last updated on Jun 13, 2023.
Note: This document contains side effect information about pozelimab. Some dosage forms listed on this page may not apply to the brand name Veopoz.
Applies to pozelimab: injectable solution.
Warning
You may get infections more easily, even serious or fatal infections. Call your doctor if you have flu symptoms, cough, night sweats, headache, neck stiffness, increased sensitivity to light, confusion, or vision problems.
Make sure you are current on all vaccines before you start using pozelimab. Talk to your doctor if you are not current on your vaccines.
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Read the Patient Wallet Card about the symptoms of meningococcal or other infections and learn what symptoms to watch for. Keep the card with you at all times.
You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:
-
fever, chills, sore throat;
-
headache, neck stiffness, increased sensitivity to light;
-
confusion, drowsiness;
-
mouth sores, red or swollen gums;
-
pale skin, easy bruising, unusual bleeding; or
-
chest discomfort, wheezing, dry cough or hack, rapid weight loss.
Common side effects may include:
-
itchy, raised red patches of skin; or
-
cold symptoms such as stuffy nose, sneezing, sore throat.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to pozelimab: injectable solution.
General
Most common adverse reactions were upper respiratory tract infection, fracture, urticaria, and alopecia.[Ref]
Cardiovascular
Frequency not reported: Elevated systolic blood pressure, elevated diastolic blood pressure[Ref]
Dermatologic
Very common (10% or more): Urticaria (20%), alopecia (20%)[Ref]
Gastrointestinal
Frequency not reported: Gingival bleeding[Ref]
Hypersensitivity
Frequency not reported: Systemic hypersensitivity reactions, immune complex formation[Ref]
Local
Frequency not reported: Injection site reactions (included dermatitis and erythema)[Ref]
Metabolic
Frequency not reported: Metabolic acidosis, increased blood uric acid[Ref]
Musculoskeletal
Very common (10% or more): Fracture (30%)[Ref]
Nervous system
Frequency not reported: Serious meningococcal infections[Ref]
Other
Frequency not reported: Bacterial infections[Ref]
Respiratory
Very common (10% or more): Upper respiratory tract infection (30%)[Ref]
Genitourinary
Frequency not reported: Hematuria, proteinuria[Ref]
Hepatic
Frequency not reported: Increased liver enzymes[Ref]
More about Veopoz (pozelimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
References
1. Product Information. Veopoz (pozelimab). Regeneron Pharmaceuticals Inc. 2023;ORIG-1.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.